Profit Sharing
2022 plan-year Profit Sharing DOL Form 5500

Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan

ERISA Form 5500 plan record drawn from DOL EBSA โ€” verify with linked source filings below.

Sponsored by Meh, Inc. ยท Missouri ยท Manufacturing

What the 2023 filing shows

Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan holds $685M for 2,525 participants - about $271,207 per participant, down 24.4% over the 2022 plan year.

$685M
total plan assets (2022 EOY)
2,525
covered participants
$271,207
avg assets per participant
-24.4%
assets change YoY

The plan reported a net loss of $221M for the year โ€” a single-year figure driven by markets and benefit payments, not a measure of plan health.

Total Assets (2023)
$685M
Participants
2,525
State
Industry
Manufacturing

What the Filing Says About Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan

Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan is a Profit Sharing retirement plan sponsored by Meh, Inc., headquartered in Missouri. As of the 2022 Form 5500 filing, the plan reports $685M in total end-of-year assets and covers 2,525 participants across the Manufacturing industry. The sponsor's EIN on file with the U.S. Department of Labor is 650952696, and the plan has been effective since 2013-04-01. Its filing status is currently FILING RECEIVED.

Year over year, total assets moved from $906M at the beginning of 2022 to $685M at year-end โ€” a decline of 24.4%. Net assets (after liabilities) closed the year at $685M, with reported net income of $-221,285,494 driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.

Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows โ€” a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.

Financial Summary (2023)

Total Assets (Beginning of Year)$906M
Total Assets (End of Year)$685M
Net Assets (End of Year)$685M
Net Income$-221,285,494
Plan TypeProfit Sharing
Employer EIN650952696
Plan Effective Date2013-04-01
Filing StatusFILING RECEIVED

Sponsor Plan History (Meh, Inc.)

Year Plans Participants Total Assets
2022 1 2,525 $685M
2023 1 2,332 $779M
2024 1 2,480 $851M

Nearby Profit Sharing Plans in Missouri

Peer Profit Sharing plans โ€” same state, same plan type โ€” ranked by total assets.

Frequently Asked Questions

How much money is in the Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan?
As of the 2022 Form 5500 filing, Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan holds $685M in total assets with 2,525 participants. It is sponsored by Meh, Inc..
What type of plan is Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan?
Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan is a Profit Sharing plan. It has been effective since 2013-04-01. The plan is filed with the U.S. Department of Labor under EIN 650952696.
Who sponsors the Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan?
Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan is sponsored by Meh, Inc., located in Missouri. The sponsor's EIN is 650952696 and the plan operates in the Manufacturing industry.
How did Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan perform in 2022?
Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan declined by 24.4% during 2022, moving from $906M to $685M in total assets. Net income was $-221,285,494.
Where can I find official filings for Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan?
Official Form 5500 filings for Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan are available through the U.S. Department of Labor's EFAST2 system. Search by EIN 650952696 or plan name at efast.dol.gov.
How does Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan compare to other plans?
You can compare Mallinckrodt Pharmaceuticals Retirement Savings and Investment Plan against other Profit Sharing plans on the plan type page, or view plans in Missouri on the state page. PlainRetire tracks the 5,000 largest retirement plans in the U.S. by total assets.

Explore PlainRetire

Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2022.

Source: DOL EFAST2 filing system (efast.dol.gov) โ€” original filing retrieval by EIN 650952696.

Reference: IRS Publication 560 โ€” Retirement Plans for Small Business, contribution-limit rules.

Reference: IRS Publication 590-B โ€” Distributions from IRAs, RMD rules under SECURE Act 2.0.

Data sourced from U.S. Department of Labor Form 5500 filings (EBSA). See our methodology for details.